Attached files

file filename
EX-32.1 - EX-32.1 - Seagen Inc.d443261dex321.htm
EX-31.2 - EX-31.2 - Seagen Inc.d443261dex312.htm
EX-31.1 - EX-31.1 - Seagen Inc.d443261dex311.htm
EX-10.6 - EX-10.6 - Seagen Inc.d443261dex106.htm
EX-10.5 - EX-10.5 - Seagen Inc.d443261dex105.htm
EX-10.4 - EX-10.4 - Seagen Inc.d443261dex104.htm
EX-10.3 - EX-10.3 - Seagen Inc.d443261dex103.htm
EX-10.2 - EX-10.2 - Seagen Inc.d443261dex102.htm
EX-10.1 - EX-10.1 - Seagen Inc.d443261dex101.htm
EX-2.1 - EX-2.1 - Seagen Inc.d443261dex21.htm
10-Q - FORM 10-Q - Seagen Inc.d443261d10q.htm

Exhibit 32.2

SEATTLE GENETICS, INC.

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Seattle Genetics, Inc. (the “Company”) on Form 10-Q for the quarter ended September 30, 2017, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Todd E. Simpson, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

  (1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

  (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

/s/ Todd E. Simpson
Todd E. Simpson
Chief Financial Officer
(Principal Financial and Accounting Officer)

November 6, 2017

This certification accompanies the Form 10-Q to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of Seattle Genetics, Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the Form 10-Q), irrespective of any general incorporation language contained in such filing.